Sale of fake obesity drugs driven by high prices, weight-loss desire prompts health concern

Ozempic and Mounjaro are brand names of the 'GLP-1 receptor agonist' class of medicines, which help one manage diabetes and obesity by targeting appetite and enhancing satiety, resulting in a significant weight loss and cardiovascular benefits.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/CSpR9GP
via